GlassScriptPhysician profile
Anandaraj Subramanium
NPI 1194767657
$2,398.60
in general payments reported to CMS, 2019-2025
17 companies · $55.83 in 2025
The $55.83 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $45.65 · 2021: $2,000 · 2022: $114 · 2023: $68.91 · 2024: $113 · 2025: $55.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,668.50 | 2021 | |
| Abbott Laboratories | $170.86 | 2021-2025 | Freestyle Libre 3 |
| Abiomed | $127.25 | 2021 | |
| Xeris Pharmaceuticals, INC. | $63.19 | 2022-2024 | Gvoke Hypopen |
| Janssen Pharmaceuticals, INC | $59.49 | 2020-2021 | |
| Biogen, INC. | $46.18 | 2021-2022 | |
| Almatica Pharma LLC | $32.74 | 2022-2024 | Loreev Xr |
| Glaxosmithkline, LLC. | $30.33 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $30.13 | 2021-2024 | Airsupra |
| Merck Sharp & Dohme LLC | $29.55 | 2020 | |
| Mylan Specialty L.P. | $28.74 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $23.20 | 2021 | |
| Boston Scientific Corporation | $22.39 | 2025 | Watchman Access System |
| Pfizer INC. | $18.12 | 2024 | |
| Ibsa Pharma INC. | $17.97 | 2025 | Licart, Flector, Tirosint |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $15.12 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anandaraj Subramanium listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.